Denali Therapeutics (DNLI) Earnings Date & Reports

Denali Therapeutics Inc is a biotechnology company that is engaged in developing and discovering therapeutics to defeat neurodegeneration disease... Show more

Industry: #Biotechnology

Get AI intraday signals

A.I. Advisor

published Earnings

DNLI is expected to report earnings to fall 9.29% to -70 cents per share on July 31

Denali Therapeutics DNLI Stock Earnings Reports

Q2'25

Est.

$-0.71

Q1'25

Missed

by $0.08

Q4'24

Beat

by $0.17

Q3'24

Missed

by $0.03

Q2'24

Beat

by $0.08

The last earnings report on May 06 showed earnings per share of -77 cents, missing the estimate of -69 cents. With 277.97K shares outstanding, the current market capitalization sits at 2.08B.

View a ticker or compare two or three

Compare

DNLI